Company Filing History:
Years Active: 2025
Title: Innovations of Katie A. Spence
Introduction
Katie A. Spence is an accomplished inventor based in San Francisco, CA. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit PRMT5. Her work is crucial for advancing treatments for various diseases and conditions.
Latest Patents
Katie holds a patent for PRMT5 inhibitors and their uses. This patent relates to compounds that inhibit PRMT5, which can be utilized in the preparation of medicaments for treating diseases associated with chromosome 9p21 deletion, MTAP null, or any other MTAP deficiency. Additionally, her research focuses on the application of these compounds in cancer treatment.
Career Highlights
Katie is currently employed at Gilead Sciences, Inc., where she continues to innovate and develop new therapeutic solutions. Her expertise in the field has positioned her as a key player in the pharmaceutical industry.
Collaborations
Katie has collaborated with notable colleagues, including Megan K. Armstrong and Elbert Chin, to further her research and development efforts.
Conclusion
Katie A. Spence's contributions to the field of medicinal chemistry and her innovative work on PRMT5 inhibitors highlight her importance as an inventor. Her ongoing efforts at Gilead Sciences, Inc. continue to pave the way for advancements in medical treatments.